Pra Health Sciences Inc 's Cash & cash equivalent grew by 36.33 % in the Q1 2021 sequentially, while Current Liabilities decreased, this led to improvement in Pra Health Sciences Inc 's Quick Ratio to 0.52 a new company high.

Within Medical Laboratories industry 38 other companies have achieved higher Quick Ratio than Pra Health Sciences Inc in first quarter 2021. While Quick Ratio total ranking in the first quarter 2021 has deteriorated compared to the prior quarter from 2847 to 3247.

Explain Quick Ratio?
How much Cash & cash equivalents PRAH�s has?
What are PRAH�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PRAH Quick Ratio	(Mar 31 2021) Q1	(Dec 31 2020) Q4	(Sep 30 2020) Q3	(Jun 30 2020) Q2	(Mar 31 2020) Q1
Y / Y Current Liabilities Change	28.82 %	27.18 %	14.56 %	17.16 %	7.99 %
Y / Y Cash & cash equivalent Change	357.61 %	114.29 %	84.95 %	18.29 %	-15.07 %
Quick Ratio MRQ	0.52	0.38	0.34	0.16	0.15
PRAH's Total Ranking	# 3247	# 2847	# 3747	# 4460	# 3439
Seq. Current Liabilities Change	-0.73 %	33.27 %	-3.02 %	0.41 %	-2 %
Seq. Cash & cash equivalent Change	36.33 %	50.58 %	99.86 %	11.53 %	-36.16 %

Quick Ratio first quarter 2021 Company Ranking
Within:	No.
Medical Laboratories Industry	# 39
Healthcare Sector	# 944
Overall Market	# 3247

Quick Ratio Statistics
High	Average	Low
0.52	0.24	0.14
(Mar 31 2021)		(Mar 31 2018)

Financial Statements
Pra Health Sciences Inc 's Current Liabilities	$ 1,323 Millions	Visit PRAH's Balance sheet
Pra Health Sciences Inc 's Cash & cash equivalent	$ 690 Millions	Visit PRAH's Balance sheet
Source of PRAH's Sales		Visit PRAH's Sales by Geography

Cumulative Pra Health Sciences Inc 's Quick Ratio

PRAH's Quick Ratio for the trailling 12 Months

PRAH Quick Ratio	(Mar 31 2021) 12 Months	(Dec 31 2020) 12 Months	(Sep 30 2020) 12 Months	(Jun 30 2020) 12 Months	(Mar 31 2020) 12 Months
Y / Y Current Liabilities TTM Growth	22.44 %	17.03 %	14.96 %	9.93 %	6 %
Y / Y Cash & cash equivalent TTM Growth	139.2 %	57.43 %	37.95 %	24.44 %	23.95 %
Quick Ratio TTM	0.36	0.26	0.22	0.19	0.19
Total Ranking TTM	# 2761	# 5033	# 3346	# 2888	# 5063
Seq. Current Liabilities TTM Growth	6.74 %	6.94 %	3.19 %	3.95 %	2.03 %
Seq. Cash & cash equivalent TTM Growth	46.44 %	30.29 %	20.95 %	3.66 %	-3.63 %

Quick ratio ranking by company, industry and sector >> Back to PRAH Financial Strength Comparisons >> Go to Compare PRAH Quick Ratio to its Competitors

On the trailing twelve months basis PRAH Cash & cash equivalent more than doubled by 357.61 % in Q1 2021 year on year, faster than Current Liabilities, this led to increase in in Pra Health Sciences Inc 's Quick Ratio to 0.36, above PRAH average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 30 other companies have achieved higher Quick Ratio than Pra Health Sciences Inc . While Quick Ratio overall ranking has improved so far to 2761, from total ranking during the twelve months ending fourth quarter 2020 at 5033.

Explain Quick Ratio?
How much Cash & cash equivalents PRAH�s has?
What are PRAH�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 31
Healthcare Sector	# 835
Within the Market	# 2761

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.37	0.2	0.14
(Mar 31 2021)		(Dec 31 2018)

Companies with similar Quick Ratio in the quarter ending Mar 31 2021, within Medical Laboratories Industry	Quick Ratio	Mar 31 2021 MRQ Cash & cash equivalent	Mar 31 2021 MRQ Current Liabilities
Biocept Inc	1.32	$ 14.198 Millions	$ 10.734 Millions
Fulgent Genetics Inc	1.01	$ 151.461 Millions	$ 150.521 Millions
Bionexus Gene Lab Corp	0.82	$ 2.475 Millions	$ 3.035 Millions
Charles River Laboratories International inc	0.79	$ 465.411 Millions	$ 590.344 Millions
Quest Diagnostics Inc	0.79	$ 1,230.000 Millions	$ 1,561.000 Millions
Iqvia Holdings Inc	0.72	$ 2,402.000 Millions	$ 3,314.000 Millions
Kushco Holdings Inc	0.71	$ 34.962 Millions	$ 49.112 Millions
American Shared Hospital Services	0.69	$ 5.013 Millions	$ 7.286 Millions
Psychemedics Corporation	0.65	$ 2.190 Millions	$ 3.367 Millions
Labcorp Holdings Inc	0.56	$ 1,890.800 Millions	$ 3,368.700 Millions
Pra Health Sciences Inc	0.52	$ 690.259 Millions	$ 1,322.551 Millions
Centogene N v	0.45	$ 19.956 Millions	$ 44.236 Millions
Luna Innovations Inc	0.43	$ 11.794 Millions	$ 27.478 Millions
Icon Plc	0.40	$ 944.184 Millions	$ 2,338.359 Millions
Ppd Inc	0.34	$ 826.425 Millions	$ 2,454.619 Millions
Koninklijke Philips Nv	0.33	$ 2,782.080 Millions	$ 8,367.520 Millions
WEED, INC.	0.27	$ 0.094 Millions	$ 0.351 Millions
Advanced Container Technologies Inc	0.26	$ 0.457 Millions	$ 1.743 Millions
Nuo Therapeutics, Inc.	0.24	$ 0.157 Millions	$ 0.667 Millions
Foxo Technologies Inc	0.22	$ 1.303 Millions	$ 5.873 Millions
Radnet Inc	0.21	$ 69.885 Millions	$ 330.647 Millions

Date modified: 2026-09-12T06:15:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.